Company
ChinaShanghai Aucta Pharmaceuticals Co., Ltd., China – FDA Inspections
Inspection records and compliance data for Shanghai Aucta Pharmaceuticals Co., Ltd.. 1 FDA inspection on record, 1 Form 483, last inspected May 01, 2024.
Company Profile
This profile covers Shanghai Aucta Pharmaceuticals Co., Ltd. based in China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected May 1, 2024.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 1, 2024 | Not classified | Human Drugs | 1240857 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Standard Sci-tech Innovation (Qingdao) Pharmaceutical Technology Co., Ltd.
WuXi Biologics Biosafety Testing (Suzhou) Co., Ltd
Hangzhou Leading Pharmatech Co., Ltd.
Jiangsu AssurePharma Biotechnology Co., Ltd.
Frontage Laboratories (Suzhou) Co.,Ltd.
HEC RTC LAB
PCI Laboratories Co., Ltd
Yichang HEC ChangJiang Pharmaceutical Co Ltd
Qingdao Haohai Guangjie Testing and Technical Consulting Co., Ltd.
Seasons Biotechnology (Taizhou) Co., Ltd
Company Information
Name
Shanghai Aucta Pharmaceuticals Co., Ltd.
FEI Number
3015399061
Address
China
Country
China
ID: da861c13-1576-43bd-85cf-f57ae7bff601